Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Pressure BioSciences, Inc.    PBIO   US74112E1091

News SummaryMost relevantAll newsSector news 

Pressure Biosciences : Pressure BioSciences, Inc. to Present at the Rodman & Renshaw 8th Annual Healthcare Conference

11/02/2006 | 10:15am US/Eastern

Pressure BioSciences, Inc. (NASDAQ: PBIO) today announced that it will present at the Rodman & Renshaw 8th Annual Healthcare Conference to be held at the New York Palace Hotel, New York, NY on November 6-8, 2006. Mr. Richard T. Schumacher, PBI President and CEO, will give a corporate overview at 9:55 am (EST) on Wednesday, November 8th. Investors will be able to hear the presentation starting on November 8th and for approximately 90 days thereafter at

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly traded, early-stage company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 5 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.

Forward Looking Statements

Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-QSB for the quarter ended June 30, 2006, in the Company's Annual Report on Form 10-KSB, as amended, for the year ended December 31, 2005, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

Visit us at our website

© Business Wire 2006
React to this article
03/18 PRESSURE BIOSCIENCES : Announces the Release of PCT-HD, "The Next Generation Pro..
03/01 PRESSURE BIOSCIENCES INC : Pressure BioSciences Inc., ("PBI") (OTCQB: PBIO), Exc..
02/24 PRESSURE BIOSCIENCES INC : Publishes New SNNLive Video Intervie..
02/20 PRESSURE BIOSCIENCES : Receives First Purchase Order for its Barozyme HT48 High-..
02/11 PRESSURE BIOSCIENCES : Regulation FD Disclosure, Financial Statements and Exhibi..
02/10 PRESSURE BIOSCIENCES INC : Shifts In Government Policy Create Potential Surge Fo..
2014 PRESSURE BIOSCIENCES : Entry into a Material Definitive Agreement, Unregistered ..
2014 PRESSURE BIOSCIENCES : Entry into a Material Definitive Agreement, Unregistered ..
2014 PRESSURE BIOSCIENCES : Submission of Matters to a Vote of Security Holders (form..
2014 PRESSURE BIOSCIENCES : Ships Third Barozyme HT48 System
Income Statement Evolution
More Financials
Dynamic quotes